BlueCrest Capital Management’s Johnson & Johnson JNJ Stock Holding History

BlueCrest Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,366	Closed	-$1.64M	–	173
2024 Q1	$1.64M	Sell	10,366 -23,832	-70%	-$3.79M	0.08%	135
2023 Q4	$5.36M	Sell	34,198 -2,656	-7%	-$407K	0.21%	94
2023 Q3	$5.74M	Buy	36,854 +26,027	+240%	+$4.29M	0.25%	70
2023 Q2	$1.79M	Buy	+10,827	New	+$1.75M	0.06%	113
2019 Q3	–	Sell	-1,931	Closed	-$269K	–	623
2019 Q2	$269K	Buy	+1,931	New	+$267K	0.02%	301
2018 Q4	–	Sell	-5,648	Closed	-$780K	–	1149
2018 Q3	$780K	Sell	5,648 -14,039	-71%	-$1.87M	0.02%	551
2018 Q2	$2.39M	Sell	19,687 -12,720	-39%	-$1.59M	0.06%	284
2018 Q1	$4.15M	Sell	32,407 -112,172	-78%	-$15.2M	0.13%	162
2017 Q4	$20.2M	Buy	144,579 +135,779	+1,543%	+$18.9M	0.55%	26
2017 Q3	$1.14M	Sell	8,800 -7,878	-47%	-$1.04M	0.05%	355
2017 Q2	$2.21M	Buy	+16,678	New	+$2.13M	0.09%	312
2017 Q1	–	Sell	-16,767	Closed	-$1.93M	–	855
2016 Q4	$1.93M	Sell	16,767 -7,628	-31%	-$881K	0.11%	258
2016 Q3	$2.88M	Buy	+24,395	New	+$2.96M	0.09%	233
2015 Q3	–	Sell	-9,302	Closed	-$907K	–	957
2015 Q2	$907K	Buy	+9,302	New	+$932K	0.03%	520

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlueCrest Capital Management's JNJ Position: Q2 2024 in Review

BlueCrest Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 10,366 shares — an estimated $1.64M sold.

BlueCrest Capital Management first reported a position in JNJ in Q2 2015 and held it in 14 quarters. The position peaked at $20.2M in Q4 2017. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

BlueCrest Capital Management reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
BlueCrest Capital Management sold 10,366 Johnson & Johnson shares in Q2 2024, an estimated $1.64M.
BlueCrest Capital Management first reported a position in Johnson & Johnson in Q2 2015 and held it in 14 quarters.
BlueCrest Capital Management's Johnson & Johnson position peaked at $20.2M in Q4 2017.
3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on BlueCrest Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.